Laeis P - Search Results

1

Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension.

Sellin L, Stegbauer J, Laeis P, Rump LC. Sellin L, et al. Among authors: laeis p. J Hypertens. 2005 Nov;23(11):2083-92. doi: 10.1097/01.hjh.0000186022.74245.01. J Hypertens. 2005. PMID: 16208152 Clinical Trial.

2

Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual-Combination Therapy.

Rump LC, Ammentorp B, Laeis P, Scholze J. Rump LC, et al. Among authors: laeis p. J Clin Hypertens (Greenwich). 2016 Jan;18(1):60-9. doi: 10.1111/jch.12621. Epub 2015 Jul 14. J Clin Hypertens (Greenwich). 2016. PMID: 26176708 Free PMC article. Clinical Trial.

3

Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.

Mallion JM, Heagerty A, Laeis P. Mallion JM, et al. Among authors: laeis p. J Hypertens. 2007 Oct;25(10):2168-77. doi: 10.1097/HJH.0b013e328287ad0d. J Hypertens. 2007. PMID: 17885562 Clinical Trial.

4

Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients.

Püchler K, Nussberger J, Laeis P, Witte PU, Brunner HR. Püchler K, et al. Among authors: laeis p. J Hypertens. 1997 Dec;15(12 Pt 2):1809-12. doi: 10.1097/00004872-199715120-00094. J Hypertens. 1997. PMID: 9488244 Clinical Trial.

5

Efficacy and tolerability of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide: a subgroup analysis of patients stratified by hypertension severity, age, sex, and obesity.

Kreutz R, Ammentorp B, Laeis P, de la Sierra A. Kreutz R, et al. Among authors: laeis p. J Clin Hypertens (Greenwich). 2014 Oct;16(10):729-40. doi: 10.1111/jch.12408. Epub 2014 Sep 20. J Clin Hypertens (Greenwich). 2014. PMID: 25243781 Free PMC article. Clinical Trial.

6

Olmesartan medoxomil: influence of age, renal and hepatic function on the pharmacokinetics of olmesartan medoxomil.

von Bergmann K, Laeis P, Püchler K, Sudhop T, Schwocho LR, Gonzalez L. von Bergmann K, et al. Among authors: laeis p. J Hypertens Suppl. 2001 Jun;19(1):S33-40. doi: 10.1097/00004872-200106001-00005. J Hypertens Suppl. 2001. PMID: 11451213

7

Blood pressure response, but not adverse event incidence, correlates with dose of angiotensin II antagonist.

Püchler K, Laeis P, Stumpe KO. Püchler K, et al. Among authors: laeis p. J Hypertens Suppl. 2001 Jun;19(1):S41-8. doi: 10.1097/00004872-200106001-00006. J Hypertens Suppl. 2001. PMID: 11451214

8

Clinical efficacy of olmesartan medoxomil.

Brunner HR, Laeis P. Brunner HR, et al. Among authors: laeis p. J Hypertens Suppl. 2003 May;21(2):S43-6. doi: 10.1097/00004872-200305002-00008. J Hypertens Suppl. 2003. PMID: 12929907 Review.

9

Open-label study assessing the long-term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertension.

Volpe M, de la Sierra A, Ammentorp B, Laeis P. Volpe M, et al. Among authors: laeis p. Adv Ther. 2014 May;31(5):561-74. doi: 10.1007/s12325-014-0117-9. Epub 2014 Apr 24. Adv Ther. 2014. PMID: 24760656 Clinical Trial.

10

Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.

Volpe M, Christian Rump L, Ammentorp B, Laeis P. Volpe M, et al. Among authors: laeis p. Clin Drug Investig. 2012 Oct 1;32(10):649-64. doi: 10.1007/BF03261919. Clin Drug Investig. 2012. PMID: 22909147 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters